Eye Health Supplement Helps Protect Against Oxidative Stress, Free Radicals

New York – Bionops Laboratories has released the first eye health dietary supplement with Citicoline (Cognizin^®) from Kyowa Hakko Bio to French consumers.
The specialized eye health formulation contains a variety of ingredients to help protect the macular cells from oxidative stress caused by free radicals. In addition to Citicoline (Cognizin^®), Biomacula provides necessary doses of Vitamin E, Glutathione, Resveratrol, Gingko Biloba, and vitamins B1 and B6.
Citicoline (Cognizin^®) – a branded form of citicoline – is an essential substance for brain health, and has been shown to benefit the eyes.* Citicoline works as an antioxidant in preserving normal healthy visual function.*
This is the first dietary supplement in France that contains Citicoline (Cognizin^®) for eye health. Citicoline (Cognizin^®) is an authorized novel food ingredient in Europe. Biomacula comes in quantities of 60 and 180 capsules. For more information about Biomacula, visit http://www.bionops.eu/confort-visuel/4-biomacula.html.

About Bionops Laboratory
Specialized in the research and development of quality and effective nutritional supplements, Bionops Laboratory relies on a management team with over 20 years’ experience in the field of health and nutrition. Innovative and dynamic, Bionops Laboratory gives primary importance to research, development of formulas containing many active ingredients and optimal efficiency. Bionops Laboratory places ethics at the top of its priorities and develops formulas always marked by its quality values, transparency and efficiency. For more information, visit www.bionops.eu/.

About Citicoline (Cognizin^®)
Cognizin is a branded form of Citicoline, a natural substance found in every cell of the body and especially vital to brain health.* Citicoline is broken down during intestinal absorption and, after passing through the blood/brain barrier, is reconstituted in the brain as citicoline.* Citicoline is a water-soluble compound that supplies precursors for the synthesis of phospholipids, including phosphatidyl-choline, a major constituent of brain tissue*; helps maintain normal levels of acetylcholine, a chemical that regulates memory and cognitive function*; enhances communication between neurons*; supports visual function*; protects neural structures from free radical damage*; enhances metabolism and healthy brain activity*; and helps sustain healthy cellular mitochondria for sustained energy*. Cognizin is also highly stable, GRAS, ultra-pure and allergen-free. For more information on Cognizin, visit www.cognizin.com.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About Kyowa Hakko Europe
Kyowa Hakko Europe and Kyowa Hakko Bio Italia are the Central-North and South European sales office for Kyowa Hakko Bio Co., Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. For more information, visit Kyowa Hakko Europe GmbH at www.kyowa.eu or email at bio-chemicals@kyowa.de

Special Formula Developed by Dr. Hyla Cass to Help Boost Memory and Recall*

New York City – Dr. Hyla Cass, a renowned MD in integrative medicine, psychiatry, and addiction recovery, is offering Brain Cell Support Plus™ with Cognizin^® Citicoline.

Brain Cell Support Plus™ was designed to support optimal brain health, mental focus and mood. It contains Acetyl-L-Carnitine (ALC), plus Cognizin^®, a potent brain-health nutrient clinically shown to support mental energy, focus, attention and recall.*

The formula also provides DMAE, Phosphatidylserine, and two well-supported brain-supporting botanicals – Ginkgo Biloba and Gotu Kola – to support healthy neurotransmitter production and mood.* Additionally, Dr. Cass is now including two additional natural compounds – Huperzine A (from the Chinese club moss Huperzia serrata) and Vinpocetine (from the periwinkle plant) to aid in supporting cerebral blood-flow and memory.*

Brain Cell Support Plus™ leverages Cognizin^®, a branded form of citicoline that is an essential substance for brain health. Citicoline works to enhance communication between neurons, maintain normal levels of acetylcholine, protect neural structures, and enhance health brain activity and energy.*

“I created this unique formula myself after years of research and practice, and find that individuals with impaired memory get a marked boost in memory, focus, and overall mood from taking it. They and their families are very grateful! “said Dr Cass.

Citicoline is a compound that promotes the production of phosphatidylcholine (phospholipids), important for brain function. Phospholipids make up approximately 30% of brain tissue, aid neural communication and provide essential protection for neurons. Clinical research has shown that citicoline has multiple applications and is able to improve various aspects of the brain’s physiological activity.*

For more information about Brain Cell Support Plus, visit http://cassmd.com/products/brain-cell-support-plus/

About Dr. Hyla Cass
Nationally acclaimed innovator and expert in the fields of integrative medicine, psychiatry, and addiction recovery, Dr. Cass helps individuals to take charge of their health. One area is in withdrawing from both psychiatric medication and substances of abuse with the aid of natural supplements.

Dr. Cass appears often as a guest on national radio and television, including The Dr. Oz Show, E! Entertainment, and The View, and in national print media. She has been quoted in many national magazines, blogs for the Huffington Post, and is the author of several best-selling books including: Natural Highs, 8 Weeks to Vibrant Health, Supplement your Prescription: What Your Doctor Doesn’t Know About Nutrition, and her ebook, The Addicted Brain and How to Break Free. She has created her own line of innovative nutritional supplements.

A member of the Medical Advisory Board of the Health Sciences Institute and Taste for Life Magazine, she is also Associate Editor of Total Health Magazine, she has served on the boards of California Citizens for Health and the American College for Advancement in Medicine (ACAM). A native of Toronto, she graduated from the University of Toronto School of Medicine, interned at Los Angeles County-USC Medical Center, and completed a psychiatric residency at Cedars-Sinai Medical Center/UCLA. She is a Diplomate of the American Board of Psychiatry and Neurology (ABPN), and of the American Board of Integrative Holistic Medicine (ABIHM).

For more information, visit cassmd.com

About Cognizin^® Citicoline
Cognizin^® is a branded form of Citicoline, a natural substance found in every cell of the body and especially vital to brain health.* Citicoline is broken down during intestinal absorption and, after passing through the blood/brain barrier, is reconstituted in the brain as citicoline.* Citicoline is a water-soluble compound that supplies precursors for the synthesis of phospholipids, including phosphatidyl-choline, a major constituent of brain tissue*; helps maintain normal levels of acetylcholine, a chemical that regulates memory and cognitive function*; enhances communication between neurons*; supports visual function*; protects neural structures from free radical damage*; enhances metabolism and healthy brain activity*; and helps sustain healthy cellular mitochondria for sustained energy*. Cognizin^® is also highly stable, GRAS, ultra-pure and allergen-free. For more information on Cognizin^®, visit www.cognizin.com.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About Kyowa Hakko USA
Kyowa Hakko USA is the North American sales office for Kyowa Hakko Bio Co. Ltd. (Kyowa Hakko Bio), an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. Kyowa Hakko Bio is the maker of branded ingredients including Cognizin^® Citicoline, Lumistor^® L-Hydroxyproline, Pantesin^® Pantethine, Setria^® Glutathione, as well as Sustamine^® L-Alanyl-L-Glutamine. For more information visit www.kyowa-usa.com.

ESM Technologies’ NEM^® brand eggshell membrane is mentioned in the latest issue of Woman’s World Magazine!

NEM is referred to as “eggshell extract” on the cover that can help joints, with an article including NEM featured on page 16. The article looks at the 2 open label human clinical trials published in Clinical Interventions in Aging in 2009*, and states that eggshell membrane (NEM) is rich in compounds that soothe joints and keep shock-absorbing joint cartilage healthy.** Find it in the June 29th issue on newsstands now!

If you’re considering formulating NEM into your next joint health supplement, visit the Formulator’s Corner for more info.

*We would like to mention however, that this published study showed NEM^® worked within 7 days instead of 2 months as mentioned in the magazine.
** These statements have not been evealuated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

UK STUDY SHOWS SABINSA’S CURCUMIN C3 COMPLEX TO BE SAFE ADJUNCT TO, AND ENHANCE EFFICACY OF, FOLFOX CHEMOTHERAPY

East Windsor, NJ – Curcumin may provide added benefit in subsets of patients when administered with FOLFOX standard chemotherapy, and is a well-tolerated chemotherapy adjunct, concluded a study conducted by researchers at Leicester University, UK and published in the journal Cancer Letters.

The study, “Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy utilized Sabinsa’s Curcumin C3 Complex patented curcumin extract”, (August 10, 2015 Volume 364, Issue 2, Pages 135 – 141), which is available to anyone via Open Access funded by Cancer Research UK (http://dx.doi.org/doi:10.1016/j.canlet.2015.05.005).

Colorectal cancer patients have a greater risk of cancer spreading to the liver. Sabinsa’s Curcumin C3 Complex® was found by the researchers to be safe and tolerable as an acceptable daily adjunct in a phase I dose escalation study on colorectal cancer with liver metastatic spread. In the trial protocol Curcumin C3 Complex® was tolerated well with 2g/day dose with standard FOLFOX chemotherapy (combination of 5-Flurouracil and Oxaliplatin, two chemotherapeutic drugs). The researchers wrote that the addition of curcumin to FOLFOX treatment was well tolerated with compliance rate of 93.8%.

The researchers further found that the addition of curcumin to FOLFOX-based chemotherapy enhanced efficacy as judged from studies done on patient-derived colorectal liver metastasis indicating a promise for such treatment in situations wherein colon cancer can spread to the liver. The researchers demonstrated that curcumin alone and in combination with chemotherapy exerted anti-proliferative and pro-apoptic (killing) effects on cancer stem cells derived from the patients. The researchers plan to extend the studies further based on the promising results obtained.

“This commitment to research for both Curcumin and in particular for Sabinsa’s C3 Complex is another reason for why, time and again, researchers, marketing companies and customers choose our ingredient,” said Shaheen Majeed, Marketing Director, Sabinsa. “This is one among half a dozen studies where Curcumin C3 Complex® has been safe and effectively used to improve chemotherapeutic activity.”

This research was supported by two studentships from Hope Against Cancer, Leicester, UK, The Royal College of Surgeons (Eng), The Bowel Disease Research Foundation, by Cancer Research UK on a programme grant

A new and proprietary botanicals formulation for male enhancement

Enostim™ is a unique and proprietary formulation of active ingredients, apple and grape polyphenols, enriched with saffron. It has been specifically developed to offer a natural and safe solution for erectile dysfunction.

To know more about Enostim, click here

Study Participants Showed Increased and Longer-Lasting Level of Nitric Oxide After Only Seven Days

New York – A new randomized, double-blind, placebo-controlled, human clinical trial published in the Journal of the International Society of Sports Nutrition found, for the first time, that one week of daily oral supplementation with 200 mg of Setria® Glutathione and 2 grams of L-citrulline enhanced nitric oxide (NO) levels.1 Setria® Glutathione led to longer lasting levels of NO by preventing its oxidative reaction when ingested in combination with L-citrulline.¹

The study, led by Dr. Darryn Willoughby of Baylor University, was designed to determine the effectiveness of Glutathione and L-citrulline on improving exercise performance, based on markers of nitric oxide (NO) synthesis.1 L-citrulline is known to impact NO levels as it’s converted to L-arginine, which synthesizes NO when ingested. However, L-citrulline supplementation alone has shown conflicting results in reference to improving exercise performance. Previous studies have indicated that Glutathione stimulates L-arginine turnover and increases nitric oxide synthase (NOS). These results suggest that it may play a role in preventing oxidative reaction and sustaining the release of NO, however; its effectiveness, particularly in combination with L-citrulline, had not been determined prior to this study.

Results from the study found that after seven days of oral supplementation, levels of nitric oxide and NOx in the L-citrulline and Glutathione group showed a measured increase 30 minutes post exercise when compared to the placebo group.1 Participants of the study included 60 healthy, resistance-trained males aged 18 – 30, with a body mass index between 18.5 – 30 kg/m2, divided into four groups that received either a placebo, Setria® Glutathione (1 gram), L-citrulline (2 grams), or a combination of Setria® Glutathione (200mg) and L-citrulline (2 grams) for one week.1 To measure the impact of supplementation or placebo during the seven day study period, the groups were evaluated after completing resistance exercise sessions, including three sets of 15 repetitions at 70 – 75 percent of the estimated 1-RM involving the elbow flexors.1 Participants were assessed on their maximum muscular strength at the beginning of the study, prior to supplementation and following three sets of fifteen repetitions of the elbow flexion exercise.¹

“In this study, we were able to determine that combining Setria® Glutathione with L-citrulline not only increased blood levels of nitrite and NOx, but sustained the increases for a longer period of time, compared to placebo,” said Dr. Willoughby, Baylor University, associate professor, Health, Human Performance, and Recreation, director, Exercise and Biochemical Nutritional Lab. “The results of this first-of-its kind study indicate that Setria® Glutathione and L-citrulline may play a role in muscle protein synthesis and muscle performance when combined with resistance exercise.”

“In addition to its immune health benefits, Setria® Glutathione is known to work in the body to eliminate toxic chemicals, maintain cell proteins and act as an antioxidant,” said Danielle Citrolo, registered pharmacist and manager of technical services for Kyowa Hakko USA. “With its reputation as the ‘master antioxidant,’ due in part to its role in combatting oxidative stress, it’s encouraging to see the benefits of Setria® Glutathione supplementation extended to slowing the release of and sustaining the body’s levels of NO with L-citrulline. These results give consumers a research-backed approach to increasing the effectiveness of resistance training with regular intake of L-citrulline and Setria® Glutathione oral supplements.”

In the same paper, similar results were seen in phase one in-vitro (cell culture) and phase two rodent studies. These results combined with the human clinical trial data shows that the combination of Setria® Glutathione and L-citrulline has the same positive, long lasting benefit of enhancing nitric oxide across a variety of subjects, as well as blood levels of NOx.

About Setria® Glutathione 
Setria® Glutathione, manufactured by KYOWA HAKKO BIO CO., LTD. is a clinically studied form of glutathione that, when taken orally, has been shown to replenish the body’s reserves, which may be depleted as a result of poor lifestyle choices, stress or natural aging. Called the “master antioxidant,” glutathione helps protect cells in the body from the damaging effects of oxidative stress and toxins. Setria® Glutathione is manufactured through a patented fermentation and patent pending for increasing natural killer (NK) cell activity, is pure, vegetarian and allergen-free. For more information about Setria® Glutathione, visit www.setriaglutathione.com.

About L-Citrulline
L-Citrulline is an amino acid that plays an important role in nitric oxide metabolism and regulation. L-Citrulline is converted to L-Arginine in the body, leading to sustained increases in both L-Arginine and nitric oxide. An ingredient with application in the areas of heart health and sports nutrition, L-Citrulline is preservative-free, allergen-free, and contains no artificial flavors or colors. It’s non-hygroscopic, highly stable, and mild taste makes it suitable for use in a variety of formulations. This pure, vegetarian ingredient is also self-affirmed GRAS. Manufactured in the U.S. using a proprietary fermentation process, L-Citrulline is an ultra-pure amino acid that carries the Kyowa Quality logo, ensuring the ingredient is backed by our commitment to the highest manufacturing standards.

About Kyowa Hakko USA
Kyowa Hakko USA . is the North American sales office for KYOWA HAKKO BIO CO., LTD., an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. Kyowa is the maker of branded ingredients including Cognizin® Citicoline, Pantesin® Pantethine, Setria® Glutathione, as well as Sustamine® L-Alanyl-L-Glutamine. For more information, visit www.kyowa-usa.com.

Download: 

New Data on Gut-Muscle Axis to be Presented at 2015 ISSN Conference

CLEVELAND, OH – Ganeden Biotech, the makers of the patented probiotic GanedenBC30, today announced that new data showing the improvement of five protein utilization end points will be presented by Dr. Ralf Jäger, FISSN, CISSN, MBA at the 12th Annual International Society of Sports Nutrition (ISSN) conference, taking place June 11-13 in Austin, TX.

The presentation, titled “Probiotics Flex Their Muscles in Sports Nutrition: the Gut‐Muscle‐Axis” is scheduled for Saturday June 13th from 2:00 – 2:50pm and is based on a study, conducted by the University of Tampa and Increnovo LLC, which found that GanedenBC30 supports protein utilization as measured by a reduction of muscle soreness and increased perceived recovery.

“In our study, co-administration of GanedenBC30 with protein was able to protect the muscle from damage as shown by perceptual measures and blood work, resulting in faster recovery and most importantly, in increased performance,” said Dr. Ralf Jäger. “This is a true game changer in the world of probiotic research in sports; as this is the first study of a probiotic showing ergogenic effects in athletes.”

For conference details or to download the full program please visit SportsNutritionSociety.org

Also, catch Dr. Ralf Jäger presenting brand new, additional data on this topic a Probiotia Americas (San Diego, CA) on June 5 at 9:30am and at IFT (Chicago, IL) on July 14 at 11:00am in booth 3887. More details to come!

About Ganeden Biotech
Ganeden Biotech is at the forefront of probiotic research and product development with an extensive library of published studies and more than 100 patents for probiotic technologies in the food, beverage, animal health, and now personal care ingredients markets. Ganeden is best known for GanedenBC30 (Bacillus coagulans GBI-30, 6086), its patented, FDA GRAS, highly stable probiotic ingredient. Ganeden’s newest ingredient, Bonicel, is the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. For more information about Ganeden Biotech and licensing opportunities visit GanedenBiotech.com.

About GanedenBC30
Introducing GanedenBC30® (Bacillus coagulans GBI-30, 6086), Ganeden Biotech’s patented probiotic ingredient that can be found in more than 150 leading food, beverage and companion animal products throughout the world. Unlike most other probiotic strains, GanedenBC30 is a spore-forming organism which makes it highly stable and allows it to remain viable through most manufacturing processes, three years of shelf life and the low pH of stomach acid. The efficacy of GanedenBC30 is backed by 21 published studies showing digestive and immune support and GanedenBC30 has an exceptional safety record with FDA GRAS status from the United States FDA. It can be formulated into virtually any food, beverage and companion animal product that experiences high or low temperature, pressure or environmental extremes including all hot or refrigerated beverages! For more information, please visit GanedenBiotech.com or GanedenBC30.com.

Bangalore, India – As the opening salvo in a campaign against adulteration of Curcumin, Sabinsa Corp has filed criminal complaint against Bayir Extracts Private Limited, Bangalore, India for knowingly supplying adulterated Turmeric Oleoresin with a forged Certificate of Analysis. The filed court papers from Sabinsa and its sister company Sami Labs are requesting a Cease and Investigation into this matter.

The Complaint was filed with the Honorable VII Additional Chief Magistrate, Bangalore under the Code of Criminal Procedure, registered with the court, and referred to the Peenya Police department for further proceedings.

Results of radiocarbon testing by University of Georgia Center for Applied Isotope Studies on commercially available samples of Curcumin sold by Bayir for export to the US determined that the material was 43% synthetic.

FDA views synthetic versions of natural botanical compounds to be different from the botanical itself, thus a supplier of such material would be required to file an NDI notification with FDA, including proof of safety, for the products to be legally sold in the US.

According to Sabinsa founder Dr. Muhammed Majeed some American companies either unknowingly or with the intention of saving money buy these cheaper synthetic materials labeled as natural products. He went on to explain that the natural product may have distinctively different pharmacological activities compared to synthetically made Curcuminoid composition.

As the industry gets more serious about quality issues, identifying synthetic versions of herbal products becomes crucial. The obvious question is “what was it synthesized from? What chemicals were used, and in what process? How do you know it is safe for consumption by humans?” If a company is selling synthetic Curcumin, and not identifying that some or all of it was synthetically derived, that lack of transparency is not only misleading consumers who think they are taking a product derived from turmeric root, but has the potential to hurt people.

Synthetic copies are, however, difficult to trace in a product using routine analysis. Plant-derived products can be distinguished from synthetic products by their content of natural carbon activity. The use of DNA testing for herbal extracts is debatable, however we know the DNA technique fails when it comes to finding adulteration with synthetic material. Therefore identification and quantification of radiocarbon in these cases provides an accurate way to detect adulteration.

“With FDA requiring the dietary supplement manufacturing companies to test raw material in their products, the amount of active compounds in them have come under scrutiny for label claims,” said Dr. Majeed “In the case of turmeric, as sales have grown adulteration has become a problem because natural sourced, good quality turmeric is expensive. Unfortunately some suppliers find it easy to adulterate the plant material with cheaper synthetic material.”

Sabinsa is evaluating other steps to combat adulteration in the Curcumin market. “As the pioneer in Curcumin supply, Sabinsa has a vested interest protecting the integrity of the Curcumin market,” said Shaheen Majeed, Sabinsa’s Marketing Director. “The vast majority of published clinical studies on Curcumin are done using our C3 Complex ingredient, and that robust body of science has helped mainstream Curcumin products. We intend to ensure that consumers are getting what they expect when they take Curcumin.”

The New York Attorney General’s action earlier this year and resulting inundation of negative media coverage brought quality issues in the industry to the forefront, making it essential that the industry polices itself more actively. It is responsibility of the industry to raise standards on testing procedures to eliminate such adulteration by using the most appropriate and best available technologies and also create more robust supply chain management and control procedures to avoid such adulteration in the raw material stage.

About Sabinsa Corporation
Sabinsa‘s mission is to provide alternative and complementary natural products for human nutrition and well-­‐being. Over the past 26 years, Sabinsa has brought to market more than 100 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 110 full time scientists conducting ongoing research in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified Kosher and Halal. For more information visit, www.sabinsa.com.

Sustamine^® taken post exercise might reduce muscle protein breakdown

New York City – A University of Texas at Austin study showed taking Sustamine^® L-Alanyl-L-Glutamine inhibits signaling proteins that activate protein degradation, which helps to maximize muscle protein build-up after resistance exercise. ¹

The study published April 3rd in the Journal Amino Acids, included 89 male Spraque-Dawley rats 2-3 months of age who performed resistance exercise. Immediately post exercise, the rats were given either whey protein (.4g/kg), low-dose Sustamine (.1g/kg), high-dose Sustamine (.5g/kg) or placebo, in random order. Sixteen rats were used as sedentary controls.

The primary findings were that “Sustamine^® altered, immediately post exercise the phosphorylation state of signaling proteins in a manner that theoretically should reduce muscle protein breakdown, while whey protein accelerated the phosphorylation of proteins in the mTOR-dependent signaling pathway thereby theoretically activating muscle protein synthesis.”

Sustamine^® is a dipeptide of glutamine that provides several substantial benefits such as enhanced recovery, immune system support, and increased metabolic rate. This was one of the first studies to demonstrate its benefit on inhibiting muscle protein breakdown.

About Sustamine^®
Sustamine^® L-Alanyl-L-Glutamine is vegetarian, allergen-free and the only GRAS L-Alanyl-L-Glutamine, Sustamine^® is also tasteless, odorless, and stable in liquids. Sustamine^® is a dietary supplement and an ingredient used in food and beverages.

Sustamine^® is an ingredient that works on multiple levels to help rehydrate the body and sustain energy levels during exertion. Sustamine^® combines L-Glutamine (the most important amino acid for stimulating muscle protein synthesis) and L-Alanine (an amino acid needed for rebuilding your body’s glycogen stores). Sustamine enhances performance and recovery in three primary ways. It helps:

• Replace lost electrolytes and fluids
• Repair damaged muscle proteins
• Refill the body’s energy stores

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
** Sustamine^® is a registered trademark of KYOWA HAKKO BIO CO. LTD.

Operating at full capacity to offer Made in the USA astaxanthin to meet growing demand

Moses Lake WA, USA – AstaReal Technologies, Inc., a subsidiary of Fuji Chemical Industries Co., Ltd. of Japan, held a ceremony on May 14^th to celebrate the first anniversary of its natural algae astaxanthin production facility which began operation last year in Moses Lake, Washington. Speakers at the ceremony included Dick Deane, Mayor of Moses Lake, Kyle Lynch from the office of Senator Judy Warnick, R-Moses Lake, Jonathan Smith, Executive Director of the Grant County Economic Development Council, and Mitsunori Nishida, President of Fuji Chemical Industries. The ceremony was attended by representatives from the local sheriff, police, and fire departments, business leaders, as well as 52 employees of AstaReal Technologies.

The facility is located near the center of Washington State, approximately 3 hours to the east of Seattle. After construction was completed in May of 2014, 52 employees were hired from the surrounding area making a significant contribution to the local economy. The factory is AstaReal’ssecond algae cultivation center, following its original site located in Gustavsberg, Sweden. As in Sweden, the AstaReal plant in Moses Lake produces high quality natural astaxanthin through the cultivation of algae in a fully indoor and carefully controlled photobioreactorsystem. The Moses Lake facility has double the production capacity of the original factory in Sweden and is currently operating at full capacity to provide 100% “Made in USA” natural astaxanthin to the world market.

The Moses Lake plant makes AstaReal the world’s only supplier of natural astaxanthin with multiple manufacturing bases, allowing it to offer a plentiful and stable supply to meet the expanding demands of the dietary supplement and functional foods industries. The demand for astaxanthin is expected to grow as new research continues to show its promise in areas such as the prevention of lifestyle diseases and anti-fatigue effects. In his speech, Mitsunori Nishida, President of Fuji Chemical Industries, emphasized AstaReal’scommitment to contributing to the health of the local people and community through its business activities in Moses Lake.

Mayor Dick Deane presented Mr. Nishida with an official proclamation which stated “…AstaReal Technologies, Inc. / Fuji Chemical Industries is constantly striving to manufacture products than can make a positive contribution to people, society and our future well-being. Therefore…The Moses Lake City Council recognizes and commends Mr. Mitsunori Nishida and his staff for their outstanding and invaluable contributions to Grant County and the Moses Lake community.”

Future Prospects
In addition to its business as the leading supplier of high quality natural astaxanthin ingredients, Fuji Chemical Industries is also developing astaxanthin based products for the rapidly growing field of medical foods. It established AstaMed, Inc., a sales subsidiary in Seattle, Washington, at the end of 2014. AstaMed is planning to launch a new medical foods product by the end of the year, in addition to a line of branded dietary supplements. Several clinical trials are also planned around North America in order to investigate astaxanthin’spotential for lifestyle disease prevention and anti-fatigue effects. Fuji Chemical Industries expects further expansion of the astaxanthin market as a result of these efforts, and is considering the construction of second plant at the site in Moses Lake within the next few years.

Fuji Chemical Industries Co., Ltd.’s AstaReal Group is the world leader in the manufacture, sales, and research and development of natural algae astaxanthin. AstaReal supplies high quality natural astaxanthin to customers in the dietary supplement, food, beverage, and cosmetic industries from its two production bases in Sweden and North America. The mission of the AstaReal Group is to provide high quality natural astaxanthin bulk ingredients and innovative retail products to as many people as possible in order to make the world happier and healthier.